Literature DB >> 35964132

Reply to "Epidemiologic analysis of 8000 acute vertebral fractures: evolution of treatment and complications at 10-year follow-up": food for thought outside the box.

Rebecca Straessle1, Corina Bello2,3.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35964132      PMCID: PMC9375349          DOI: 10.1186/s13018-022-03280-5

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.677


× No keyword cloud information.
Dear Editor, With great interest we read the retrospective cohort study by Bigdon et al. entitled “Epidemiologic analysis of 8000 acute vertebral fractures: evolution of treatment and complications at 10-year follow-up” [1]. The authors are to be congratulated on the extensive work they performed leading up to this large study. We would like to raise a number of points in connection with their work. First, the authors state that fewer surgical therapies were performed before and after the 10-year study period. Nowadays, however, non-surgeons such as interventional neuroradiologists [2] also perform vertebroplasty and kyphoplasty [3]. Despite an increase in the need for early reoperation, overall and 5-year reoperation rates were comparable for non-surgical and surgical interventionists alike [3]. In a recent study, non-surgeons even experienced lower postoperative infection rates [3]. It might be interesting to compare the trend in surgical interventions for osteoporotic and acute vertebral fractures conducted by neuroradiologists in the same centre during the study period, in order to draw more accurate conclusions about changing treatment strategies and the changes in the number of interventions. Second, implant failures, surgical site infections and postoperative neurological deterioration were reported by Bigdon et al. as the most common complications. However, current literature still mentions refractures in adjacent vertebrae as one of the major risks after vertebroplasty (at around 20%) [4]. It might be interesting to address this adverse effect and conduct further investigations on alternative determinants of surgical outcome as for example, the incidence of refractures in delayed surgical treatment after acute fractures, where literature is still scarce. Such findings should then be incorporated into personalised treatment decisions. Postoperative anti-osteoporotic treatment after vertebroplasty lowers the risk for refractures [5]. Also, preventive measures, as simple as optimised positioning, may help alleviate refracture incidence [6]. Moreover, the type of anaesthesia—such as local anaesthesia—might help prevent refractures [6]. Local anaesthesia for vertebroplasty or kyphoplasty is safe and regularly used in neurointerventional radiology [2]. Both patient positioning and anaesthesia type should be optimised by close interdisciplinary collaboration. Next, the authors do not address preoperative optimisation for surgery, intraoperative care, and postoperative care as important influencers of patient outcome. They address persistent pain as a major complication. However, the time interval between vertebroplasty and follow-up impacts conclusions regarding pain improvement attributable to the surgical intervention. In osteoporotic thoracolumbar vertebral compression fractures treated with vertebroplasty, there is evidence for a significant reduction in pain scores in the acute setting (one day and two weeks post-intervention [7]) but not regarding pain three months after vertebroplasty [8] or chronic pain [9, 10]. Bigdon et al. only recognised persistent pain (defined as pain after 6 weeks [11]) as a major complication. It would be interesting to see such trends in pain scores in their cohort of patients including different fracture etiology. Also, strategies to proactively prevent chronic postoperative pain, such as preoperative analgesia, are vital [12] and deserve to be addressed. Improvements in quality of recovery from vertebroplasty could be achieved with pain relief based on a combination of medications with various mechanisms of action [12]. The use of local anaesthesia in the preoperative setting, as well as intraoperatively in combination with monitored anaesthesia care, has significant effects on orthopaedic outcome, overall pain scores, time to recovery and mobilisation, and is crucial in the multimorbid elderly generation [13]. Moreover, like local anaesthesia applied by anaesthetists, vertebral cancellous bone infiltration applied by surgeons may also alleviate intra- and postoperative pain [14]. Therefore, it is paramount to end silo thinking. We must create interdisciplinary enhanced-recovery-after-surgery protocols and standardise shared decision-making processes for preoperative and intraoperative patient-centred treatment.
  13 in total

1.  Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study.

Authors:  M H J Voormolen; W P T M Mali; P N M Lohle; H Fransen; L E H Lampmann; Y van der Graaf; J R Juttmann; X Jansssens; H J J Verhaar
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

2.  Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures: a 12-month randomized follow-up, controlled trial.

Authors:  Jordi Blasco; Angeles Martinez-Ferrer; Juan Macho; Luis San Roman; Jaume Pomés; Josep Carrasco; Ana Monegal; Nuria Guañabens; Pilar Peris
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

Review 3.  Anesthesia care in the interventional neuroradiology suite: an update.

Authors:  Corina Bello; Chanannait Paisansathan; Thomas Riva; Markus M Luedi; Lukas Andereggen
Journal:  Curr Opin Anaesthesiol       Date:  2022-07-05       Impact factor: 2.733

4.  Kyphoplasty and Vertebroplasty Performed by Surgeons versus Nonsurgeons: Trends in Procedure Rates, Complications, and Revisions.

Authors:  William B Hogan; Alexander Philips; Daniel Alsoof; Christopher L McDonald; George Anderson; Andrew S Zhang; Alan H Daniels
Journal:  World Neurosurg       Date:  2022-05-10       Impact factor: 2.210

5.  Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study.

Authors:  Rikke Rousing; Mikkel O Andersen; Stig M Jespersen; Karsten Thomsen; Jens Lauritsen
Journal:  Spine (Phila Pa 1976)       Date:  2009-06-01       Impact factor: 3.468

6.  Analysis of percutaneous kyphoplasty under different types of anesthesia for the treatment of multiple osteoporotic vertebral fractures.

Authors:  Shuai Zhang; Shuang Xu; Jin Yang; Song Wang; Qing Wang
Journal:  BMC Musculoskelet Disord       Date:  2020-11-12       Impact factor: 2.362

7.  A retrospective analysis of the effects of different analgesics on the pain of patients with traumatic thoracolumbar fractures in the peri-treatment period.

Authors:  Hao Yuan; Quan-Yuan Chang; Ting-Ting Li; Liu-Lin Xiong; Jie Chen; Ya-Ting Wang; Zong-Jin Gan; Song Wen
Journal:  J Orthop Surg Res       Date:  2021-04-17       Impact factor: 2.359

Review 8.  Risk factors for secondary fractures to percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a systematic review.

Authors:  Wei Mao; Fei Dong; Guowei Huang; Peiliang He; Huan Chen; Shengnan Qin; Aiguo Li
Journal:  J Orthop Surg Res       Date:  2021-10-30       Impact factor: 2.359

9.  A randomized trial of balloon kyphoplasty and nonsurgical management for treating acute vertebral compression fractures: vertebral body kyphosis correction and surgical parameters.

Authors:  Jan Van Meirhaeghe; Leonard Bastian; Steven Boonen; Jonas Ranstam; John B Tillman; Douglas Wardlaw
Journal:  Spine (Phila Pa 1976)       Date:  2013-05-20       Impact factor: 3.468

10.  Evaluation of the analgesic effect of vertebral cancellous bone infiltration anaesthesia during vertebroplasty.

Authors:  Zhaofei Zhang; Feng Jiao; Yonghui Feng; Chunliang Xie; Fengwei Qin; Sineng Zhang; Donghua Liu; Wang Tang
Journal:  J Orthop Surg Res       Date:  2020-08-20       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.